Literature DB >> 15732094

Phenotypes of the N88S Berardinelli-Seip congenital lipodystrophy 2 mutation.

Michaela Auer-Grumbach1, Beate Schlotter-Weigel, Hanns Lochmüller, Gertrud Strobl-Wildemann, Piet Auer-Grumbach, Renate Fischer, Hans Offenbacher, Ernst Bernhard Zwick, Tanja Robl, Gerald Hartl, Hans-Peter Hartung, Klaus Wagner, Christian Windpassinger.   

Abstract

Recently, two missense mutations (N88S, S90L) in the Berardinelli-Seip congenital lipodystrophy gene have been identified in autosomal dominant distal hereditary motor neuropathy and Silver syndrome. We report the phenotypic consequences of the N88S mutation in 90 patients of 1 large Austrian family and two unrelated German families. Variation in the clinical and electrophysiological phenotype enabled us to distinguish six subtypes. In 4.4%, the disorder was not penetrant. Twenty percent of the patients were subclinically affected; some of these patients could only be detected by pathological nerve conduction studies. A distal hereditary motor neuropathy type V phenotype characterized by predominant hand muscle involvement was found in 31.1%, whereas 14.5% showed typical Silver syndrome with amyotrophy of the small hand muscles and spasticity of the lower extremities. Moreover, the phenotype present in 20% was compatible with Charcot-Marie-Tooth disease. In 10%, the clinical diagnosis of pure or complicated hereditary spastic paraparesis was made. Electrophysiological studies showed an axonal neuropathy but also chronodispersion of compound motor action potentials and conduction blocks. Sensory nerve conduction studies were rarely pathological. Our study indicates that the dominant N88S mutation in the Berardinelli-Seip congenital lipodystrophy gene 2 leads to a broad spectrum of motor neuron disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15732094     DOI: 10.1002/ana.20410

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  30 in total

1.  A novel de novo MFN2 mutation causing CMT2A with upper motor neuron signs.

Authors:  S Ajroud-Driss; F Fecto; K Ajroud; Y Yang; S Donkervoort; N Siddique; T Siddique
Journal:  Neurogenetics       Date:  2009-04-07       Impact factor: 2.660

2.  ALS and MMN mimics in patients with BSCL2 mutations: the expanding clinical spectrum of SPG17 hereditary spastic paraplegia.

Authors:  Thomas Musacchio; Ann-Kathrin Zaum; Nurcan Üçeyler; Claudia Sommer; Nora Pfeifroth; Karlheinz Reiners; Erdmute Kunstmann; Jens Volkmann; Simone Rost; Stephan Klebe
Journal:  J Neurol       Date:  2016-10-13       Impact factor: 4.849

Review 3.  Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease.

Authors:  D Pareyson; V Scaioli; M Laurà
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 4.  Unraveling the genetics of distal hereditary motor neuronopathies.

Authors:  Joy Irobi; Ines Dierick; Albena Jordanova; Kristl G Claeys; Peter De Jonghe; Vincent Timmerman
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

5.  Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies.

Authors:  Magdalena Zimoń; Jonathan Baets; Michaela Auer-Grumbach; José Berciano; Antonio Garcia; Eduardo Lopez-Laso; Luciano Merlini; David Hilton-Jones; Meriel McEntagart; Andrew H Crosby; Nina Barisic; Eugen Boltshauser; Christopher E Shaw; Guida Landouré; Christy L Ludlow; Rachelle Gaudet; Henry Houlden; Mary M Reilly; Kenneth H Fischbeck; Charlotte J Sumner; Vincent Timmerman; Albena Jordanova; Peter De Jonghe
Journal:  Brain       Date:  2010-05-11       Impact factor: 13.501

6.  Inhibition of TFG function causes hereditary axon degeneration by impairing endoplasmic reticulum structure.

Authors:  Christian Beetz; Adam Johnson; Amber L Schuh; Seema Thakur; Rita-Eva Varga; Thomas Fothergill; Nicole Hertel; Ewa Bomba-Warczak; Holger Thiele; Gudrun Nürnberg; Janine Altmüller; Renu Saxena; Edwin R Chapman; Erik W Dent; Peter Nürnberg; Anjon Audhya
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

7.  The first Italian family with evidence of pyramidal impairment as phenotypic manifestation of Silver syndrome BSCL2 gene mutation.

Authors:  Gianfranco Cafforio; Rosanna Calabrese; Nicola Morelli; Michelangelo Mancuso; Selina Piazza; Andrea Martinuzzi; Maria Teresa Bassi; Francesco Crippa; Gabriele Siciliano
Journal:  Neurol Sci       Date:  2008-07-09       Impact factor: 3.307

Review 8.  Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.

Authors:  John K Fink
Journal:  Acta Neuropathol       Date:  2013-07-30       Impact factor: 17.088

9.  Re-analysis of an original CMTX3 family using exome sequencing identifies a known BSCL2 mutation.

Authors:  Rabia Chaudhry; Aditi Kidambi; Megan Hwa Brewer; Anthony Antonellis; Katherine Mathews; Garth Nicholson; Marina Kennerson
Journal:  Muscle Nerve       Date:  2013-03-29       Impact factor: 3.217

10.  A novel 16p locus associated with BSCL2 hereditary motor neuronopathy: a genetic modifier?

Authors:  Esther Brusse; Danielle Majoor-Krakauer; Bianca M de Graaf; Gerhard H Visser; Sigrid Swagemakers; Agnita J W Boon; Ben A Oostra; Aida M Bertoli-Avella
Journal:  Neurogenetics       Date:  2009-04-24       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.